Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.
<h4>Background</h4>There are urgent needs for rapid and accurate drug susceptibility testing of M. tuberculosis. GenoType MTBDRsl is a new molecular kit designed for rapid identification of the resistance to the second-line antituberculosis drugs with a single strip. In recent years, it...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0055292&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849703717680447488 |
|---|---|
| author | Yan Feng Sijun Liu Qungang Wang Liang Wang Shaowen Tang Jianming Wang Wei Lu |
| author_facet | Yan Feng Sijun Liu Qungang Wang Liang Wang Shaowen Tang Jianming Wang Wei Lu |
| author_sort | Yan Feng |
| collection | DOAJ |
| description | <h4>Background</h4>There are urgent needs for rapid and accurate drug susceptibility testing of M. tuberculosis. GenoType MTBDRsl is a new molecular kit designed for rapid identification of the resistance to the second-line antituberculosis drugs with a single strip. In recent years, it has been evaluated in many settings, but with varied results. The aim of this meta-analysis was to synthesize the latest data on the diagnostic accuracy of GenoType MTBDRsl in detecting drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol, in comparison with the phenotypic drug susceptibility test.<h4>Methods</h4>This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The search terms of "MTBDRsl" and "tuberculosis" were used on PubMed, EMBASE, and Web of Science. QUADAS-2 was used to assess the quality of included studies. Data were analyzed by Meta-Disc 1.4. We calculated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and corresponding 95% confidence interval (CI) for each study. From these calculations, forest plots and summary receiver operating characteristic (SROC) curves were produced.<h4>Results</h4>Patient selection bias as well as flow and timing bias were observed in most studies. The summarized sensitivity (95% CI) was 0.874(0.845-0.899), 0.826(0.777-0.869), 0.820(0.772-0.862), 0.444(0.396-0.492), and 0.679(0.652-0.706) for fluoroquinolones, amikacin, capreomycin, kanamycin, and ethambutol, respectively. The specificity (95% CI) was 0.971(0.961-0.980), 0.995(0.987-0.998), 0.973(0.963-0.981), 0.993(0.985-0.997), and 0.799(0.773-0.823), respectively. The AUC (standard error) were 0.9754(0.0203), 0.9300(0.0598), 0.9885(0.0038), 0.9689(0.0359), and 0.6846(0.0550), respectively.<h4>Conclusion</h4>Genotype MTBDRsl showed good accuracy for detecting drug resistance to fluoroquinolones, amikacin and capreomycin, but it may not be an appropriate choice for kanamycin and ethambutol. The lack of data did not allow for proper evaluation of the test on clinical specimens. Further systematic assessment of diagnostic performance should be carried out on direct clinical samples. |
| format | Article |
| id | doaj-art-dcc041ca347546d5a7deab4dd8007074 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-dcc041ca347546d5a7deab4dd80070742025-08-20T03:17:08ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0182e5529210.1371/journal.pone.0055292Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis.Yan FengSijun LiuQungang WangLiang WangShaowen TangJianming WangWei Lu<h4>Background</h4>There are urgent needs for rapid and accurate drug susceptibility testing of M. tuberculosis. GenoType MTBDRsl is a new molecular kit designed for rapid identification of the resistance to the second-line antituberculosis drugs with a single strip. In recent years, it has been evaluated in many settings, but with varied results. The aim of this meta-analysis was to synthesize the latest data on the diagnostic accuracy of GenoType MTBDRsl in detecting drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol, in comparison with the phenotypic drug susceptibility test.<h4>Methods</h4>This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. The search terms of "MTBDRsl" and "tuberculosis" were used on PubMed, EMBASE, and Web of Science. QUADAS-2 was used to assess the quality of included studies. Data were analyzed by Meta-Disc 1.4. We calculated the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) and corresponding 95% confidence interval (CI) for each study. From these calculations, forest plots and summary receiver operating characteristic (SROC) curves were produced.<h4>Results</h4>Patient selection bias as well as flow and timing bias were observed in most studies. The summarized sensitivity (95% CI) was 0.874(0.845-0.899), 0.826(0.777-0.869), 0.820(0.772-0.862), 0.444(0.396-0.492), and 0.679(0.652-0.706) for fluoroquinolones, amikacin, capreomycin, kanamycin, and ethambutol, respectively. The specificity (95% CI) was 0.971(0.961-0.980), 0.995(0.987-0.998), 0.973(0.963-0.981), 0.993(0.985-0.997), and 0.799(0.773-0.823), respectively. The AUC (standard error) were 0.9754(0.0203), 0.9300(0.0598), 0.9885(0.0038), 0.9689(0.0359), and 0.6846(0.0550), respectively.<h4>Conclusion</h4>Genotype MTBDRsl showed good accuracy for detecting drug resistance to fluoroquinolones, amikacin and capreomycin, but it may not be an appropriate choice for kanamycin and ethambutol. The lack of data did not allow for proper evaluation of the test on clinical specimens. Further systematic assessment of diagnostic performance should be carried out on direct clinical samples.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0055292&type=printable |
| spellingShingle | Yan Feng Sijun Liu Qungang Wang Liang Wang Shaowen Tang Jianming Wang Wei Lu Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. PLoS ONE |
| title | Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. |
| title_full | Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. |
| title_fullStr | Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. |
| title_full_unstemmed | Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. |
| title_short | Rapid diagnosis of drug resistance to fluoroquinolones, amikacin, capreomycin, kanamycin and ethambutol using genotype MTBDRsl assay: a meta-analysis. |
| title_sort | rapid diagnosis of drug resistance to fluoroquinolones amikacin capreomycin kanamycin and ethambutol using genotype mtbdrsl assay a meta analysis |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0055292&type=printable |
| work_keys_str_mv | AT yanfeng rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis AT sijunliu rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis AT qungangwang rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis AT liangwang rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis AT shaowentang rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis AT jianmingwang rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis AT weilu rapiddiagnosisofdrugresistancetofluoroquinolonesamikacincapreomycinkanamycinandethambutolusinggenotypemtbdrslassayametaanalysis |